Publications

Clinical Research

  • Charvet C., Boutron I., Morvan Y., Le Berre C., Touboul S., Gaillard R., Fried E., Chevance A., How to
  • measure mental pain: a systematic review assessing measures of mental pain, Evid Based Ment
  • Health. 2022 Nov;25(4):e4.
  • Chevance A., Tomlinson A., Ravaud P., Touboul S., Henshall C., Tran V-T, Cipriani A., Important
  • adverse events to be evaluated in antidepressant trials and meta-analysis: a large international
  • preference study, Evid Based Ment Health. 2022 Dec;25(e1):e41-e48
  •  Chevance A., Ravaud P., Cornelius V., Mayo-Wilson E., Furukawa T., Designing clinically useful
  • psychopharmacological trials: challenges and ways forward, The Lancet Psychiatry, 2022
  • Jul;9(7):584-594
  •  Chevance A., Fortel A., Jouannin, A., Denis F., Mamzer M-F., Ravaud Ph., Sidorkiewicz S.,
  • Acceptability of and willingness to take digital pills by patients, the public and healthcare
  • professionals: qualitative content analysis of a large online survey of a representative sample, J
  • Med Internet Res. 2022 Feb 18;24(2):e25597.
  •  Chevance A., Ravaud P., Tomlinson A., Le Berre C., Teufer B., Touboul S., Fried E., Gartlehner G.,
  • Cipriani A., Tran V-T., Identifying outcomes for depression that matter to patients, informal
  • 3
  • caregivers, and health-care professionals: qualitative content analysis of a large international online
  • survey, The Lancet Psychiatry, 2020; 7(8):692-702.
  •  Chevance A, Tran V-T, Ravaud P. Controversy and Debate Series on Core Outcome Sets. Paper 1:
  • Improving the generalizability and credibility of core outcome sets (COS) by a large and
  • international participation of diverse stakeholders. J Clin Epidemiol. 2020; 125:206-212.e1.
  •  Chevance A, Tran V-T, Ravaud P. Controversy and Debate Series on Core Outcome Sets. Paper 7:
  • Response to comments on the paper 2-6 re « Improving the generalizability and credibility of Core
  • Outcome Sets (COSs) by involving large international sample of participants ». J Clin Epidemiol.
  • 2020;125:232‑4.
  •  Chevance A., Naudet F., Gaillard R., Porcher R., Ravaud P., «Power behind the throne: a clinical trial
  • simulation study evaluating the impact of controllable design factors on the power of
  • antidepressant trials”, International Journal of Methods in Psychiatric Research, 2019, doi:
  • 10.1002/mpr.1779
  •  Chevance A., Daouda O., Morvan Y., Salvador A. Legeron P., Saporta G., Hocine N., Gaillard G.: «
  • Impact of work-related psychosocial risk factors on mental health: A cross-sectional study in the
  • French working population », Plos One, doi: 10.1371/journal.pone.0233472 , 2020
  •  Chevance A., Gourion D., Hoertel N., Llorca P-M., Thomas P., Bocher R., Moro M-R., Laprévote V.,
  • Benyamina A., Fossati P., Masson P., Leaune E., Leboyer M., Gaillard R., Ensuring mental health care
  • during the SARS-CoV-2 epidemic in France: A narrative review. L’Encephale. 2020;46(3):193‑201.
  •  Mengin A., Allé MC., Rolling J., Ligier F., Schroder C., Lalanne L., Berna F., Jardri R., Vaiva G.,
  • Geoffroy PA., Brunault P., Thibault F., Chevance A., Giersch A., [Psychopathological consequences
  • of confinement]. L’Encephale. 2020;46(3S):S43‑52.
  •  Hoertel N., Jaffré C., Pascal de Raykeer R., McMahon K., Barrière S., Blumenstock Y., Portefaix C.,
  • Raucher-Chené D., Béra-Potelle C., Cuervo-Lombard C. Chevance A., Guérin-Langlois C., Lemogne
  • C., Airagnes G., Peyre H., Kaladjian A., Limosin F., CSA study group : « Subsyndromal and Syndromal
  • Depressive Symptoms among Older Adults with Schizophrenia Spectrum Disorder: Prevalence and
  • Associated Factors in a Multicenter Study ». Journal of Affective Disorders, 251, 2019: 60-70.
  •  Peyre H., Hoertel N., Rivollier F., Landman B., McMahon K., Chevance A., Lemogne C., Delorme R.,
  • Blanco C., Limosin F.: « Latent Class Analysis of the Feared Situations of Social Anxiety Disorder: A
  • Population-Based Study ». Depression and Anxiety 33, no 12 (2016): 1178-87.